Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 16Neoplasms 4Neoplasm Metastasis 4Prostatic Neoplasms 3Multiple Myeloma 3Giant Cell Tumor of Bone 3Carcinoma, Renal Cell 3Smoldering Multiple Myeloma 2Recurrence 2Osteoporosis 2Melanoma 2Kidney Neoplasms 2Bone Cysts, Aneurysmal 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Cancer Metastatic 1Parathyroid Neoplasms 1Osteoporotic Fractures 1Osteopetrosis, mild autosomal recessive form 1Osteopetrosis, Autosomal Recessive 7 1Osteoblastoma 1Neoplastic Cells, Circulating 1Musculoskeletal Pain 1Mastocytosis, Systemic 1Lung Neoplasms 1Inflammatory Breast Neoplasms 1Hyperparathyroidism, Primary 1Granuloma, Giant Cell 1Giant Cell Tumors 1

Interventions

pembrolizumab 37Gemcitabine 29Nivolumab 20Cisplatin 19atezolizumab 15avelumab 14Docetaxel 13enfortumab vedotin 10Carboplatin 10durvalumab 9Magnetic Resonance Spectroscopy 9Ipilimumab 8Paclitaxel 7Pemetrexed 6toripalimab 5cabozantinib 5Fluorodeoxyglucose F18 5sacituzumab govitecan 4cabazitaxel 4Taxes 4vinflunine 3tremelimumab 3pemigatinib 3X-Rays 3Standard of Care 3Specimen Handling 3Radiotherapy 3Mitomycin 3Immunotherapy 3Immunoglobulin G 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Transitional Cell × Denosumab × Clear all
NCT03520231 2021-11-23

Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases

University Health Network, Toronto

Phase 2 Completed
6 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Kidney Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡